Feb. 16, 2022
Russian figure skater Kamila Valieva said her optimistic drug check was induced by a mix-up with her grandfather’s heart medication, in accordance to Reuters.
Denis Oswald, the long term chair of the Intercontinental Olympic Committee’s disciplinary fee, said Valieva talked about the combine-up at a Court of Arbitration for Activity hearing, which was convened to identify whether or not she must be allowed to go on competitiveness.
“Her argument was this contamination took place with a solution her grandfather was using,” Oswald instructed reporters.
Valieva, a 15-calendar year-previous skater for the Russian Olympic Committee, was cleared to compete in the women’s solitary celebration after a panel of three judges agreed with the Russian anti-doping agency’s final decision to carry a ban on her.
On the other hand, the court did not tackle the merits of the drug situation, Reuters noted. The Russian anti-doping company, known as RUSADA, will hold a hearing following the Wintertime Games conclude.
Valieva was examined at her national championship on Dec. 25. The constructive final result for the banned angina drug trimetazidine wasn’t uncovered till Feb. 8, right after she experienced already competed at the Beijing Game titles in the workforce occasion.
Valieva’s sample included two other substances that are occasionally made use of to assistance the heart but aren’t on the banned list, according to The New York Occasions. The two substances — hypoxen and L-carnitine — also had been listed on her doping command variety.
The discovery of various related substances in an elite athlete, specially a single so youthful, has been cited as unconventional, the newspaper described.
“It’s a trifecta of substances — two of which are allowed, and a person that is not allowed,” Travis Tygart, the main govt of the U.S. Anti-Doping Company, informed the newspaper.
The gains of that combination “seem to be aimed at expanding endurance, lowering tiredness and selling bigger performance,” he stated.
The World Anti-Doping Agency has questioned why RUSADA didn’t reply to the beneficial end result sooner, Reuters claimed.
Oswald also explained that Valieva’s “B” sample hadn’t nonetheless been analyzed, Reuters documented. Under anti-doping guidelines, an athlete’s urine is analyzed two times. If the “A” sample is constructive, the tests lab must inform the responsible authority, this kind of as RUSADA in this situation.
The athlete can then waive the right to have a “B” sample taken but concede to the drug demand. Normally, disciplinary strategies can’t commence until both of those the “A” and “B” samples are tested.
RUSADA also has not responded to inquiries about why Valieva’s “B” sample hasn’t been examined, Reuters described.